Published Medical Papers

Please see below a list of Prof Schilling’s most recent medical publications relating to our work in AF.

 

  1. TEMPORARY REMOVAL: 2017 HRS/EHRA/ECAS/APHRS/SOLAECE Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation.

    Calkins, H, Hindricks, G, Cappato, R, Kim, YH, Saad, EB, Aguinaga, L et al..

    Heart Rhythm. 2017; :.

    PubMed PMID:28506916.

    doi: 10.1016/j.hrthm.2017.05.012.
  2. Characterization and consistency of interactions of triggers and substrate at the onset of paroxysmal atrial fibrillation.

    Jones, DG, Markides, V, Chow, AW, Schilling, RJ, Kanagaratnam, P, Wong, T et al..

    Europace. 2017; :.

    PubMed PMID:28339601.

    doi: 10.1093/europace/euw229.
  3. Uninterrupted Dabigatran versus Warfarin for Ablation in Atrial Fibrillation.

    Calkins, H, Willems, S, Gerstenfeld, EP, Verma, A, Schilling, R, Hohnloser, SH et al..

    N. Engl. J. Med. 2017;376 (17):1627-1636.

    PubMed PMID:28317415.

    doi: 10.1056/NEJMoa1701005.
  4. Are cardiovascular risk factors also associated with the incidence of atrial fibrillation? A systematic review and field synopsis of 23 factors in 32 population-based cohorts of 20 million participants.

    Allan, V, Honarbakhsh, S, Casas, JP, Wallace, J, Hunter, R, Schilling, R et al..

    Thromb. Haemost. 2017;117 (5):837-850.

    PubMed PMID:28229164. PubMed Central PMC5442605.

    doi: 10.1160/TH16-11-0825.
  5. Validation of a High-Fidelity Electrophysiology Simulator and Development of a Proficiency-Based Simulator Training Program.

    Ullah, W, Hunter, RJ, Finlay, M, Earley, MJ, McLean, A, Marazzi, R et al..

    Simul Healthc. 2017;12 (1):41-46.

    PubMed PMID:28146452.

    doi: 10.1097/SIH.0000000000000197.
  6. Safety and mid-term outcome of catheter ablation of ventricular tachycardia in octogenarians.

    Frontera, A, Panniker, S, Breitenstein, A, Bruno, VD, Connolly, GM, Wilson, D et al..

    Europace. 2016; :.

    PubMed PMID:27974359.

    doi: 10.1093/europace/euw236.
  7. Panoramic characterization of endocardial left atrial activation during human persistent AF: Insights from non-contact mapping.

    Lee, G, McLellan, AJ, Hunter, RJ, Lovell, MJ, Finlay, M, Ullah, W et al..

    Int. J. Cardiol. 2017;228 :406-411.

    PubMed PMID:27870970.

    doi: 10.1016/j.ijcard.2016.11.085.
  8. Adenosine-guided pulmonary vein isolation versus conventional pulmonary vein isolation in patients undergoing atrial fibrillation ablation: An updated meta-analysis.

    Papageorgiou, N, Providência, R, Srinivasan, N, Bronis, K, Costa, FM, Cavaco, D et al..

    Int. J. Cardiol. 2017;227 :151-160.

    PubMed PMID:27863291.

    doi: 10.1016/j.ijcard.2016.11.152.
  9. Medium-term outcomes of idiopathic ventricular fibrillation survivors and family screening: a multicentre experience.

    Honarbakhsh, S, Srinivasan, N, Kirkby, C, Firman, E, Tobin, L, Finlay, M et al..

    Europace. 2016; :.

    PubMed PMID:27738067.

    doi: 10.1093/europace/euw251.
  10. A dolus of i.v. amiodarone.

    Finlay, MC, Specterman, M, Schilling, RJ.

    Eur. Heart J. 2017;38 (17):1336-1338.

    PubMed PMID:27469374.

    doi: 10.1093/eurheartj/ehw327.
  11. Randomized trial comparing pulmonary vein isolation using the SmartTouch catheter with or without real-time contact force data.

    Ullah, W, McLean, A, Tayebjee, MH, Gupta, D, Ginks, MR, Haywood, GA et al..

    Heart Rhythm. 2016;13 (9):1761-7.

    PubMed PMID:27173976.

    doi: 10.1016/j.hrthm.2016.05.011.
  12. Endocardial biventricular defibrillator implantation in a patient with superior vena cava obstruction.

    Finlay, MC, Lall, K, Hunter, RJ, Schilling, RJ.

    Europace. 2016;18 (4):500.

    PubMed PMID:26917620. PubMed Central PMC4865057.

    doi: 10.1093/europace/euv052.
  13. Catheter ablation of atrial fibrillation in patients with heart failure: impact of maintaining sinus rhythm on heart failure status and long-term rates of stroke and death.

    Ullah, W, Ling, LH, Prabhu, S, Lee, G, Kistler, P, Finlay, MC et al..

    Europace. 2016;18 (5):679-86.

    PubMed PMID:26843584.

    doi: 10.1093/europace/euv440.
  14. Point-by-Point Radiofrequency Ablation Versus the Cryoballoon or a Novel Combined Approach: A Randomized Trial Comparing 3 Methods of Pulmonary Vein Isolation for Paroxysmal Atrial Fibrillation (The Cryo Versus RF Trial).

    Hunter, RJ, Baker, V, Finlay, MC, Duncan, ER, Lovell, MJ, Tayebjee, MH et al..

    J. Cardiovasc. Electrophysiol. 2015;26 (12):1307-14.

    PubMed PMID:26727045.

    doi: 10.1111/jce.12846.
  15. The Impact of Known Heart Disease on Long-Term Outcomes of Catheter Ablation in Patients with Atrial Fibrillation and Left Ventricular Systolic Dysfunction: A Multicenter International Study.

    Prabhu, S, Ling, LH, Ullah, W, Hunter, RJ, Schilling, RJ, McLellan, AJ et al..

    J. Cardiovasc. Electrophysiol. 2016;27 (3):281-9.

    PubMed PMID:26707369.

    doi: 10.1111/jce.12899.
  16. The lung impedance monitoring in treatment of chronic heart failure (the LIMIT-CHF study).

    Domenichini, G, Rahneva, T, Diab, IG, Dhillon, OS, Campbell, NG, Finlay, MC et al..

    Europace. 2016;18 (3):428-35.

    PubMed PMID:26683599.

    doi: 10.1093/europace/euv293.
  17. Comorbidity of atrial fibrillation and heart failure.

    Ling, LH, Kistler, PM, Kalman, JM, Schilling, RJ, Hunter, RJ.

    Nat Rev Cardiol. 2016;13 (3):131-47.

    PubMed PMID:26658575.

    doi: 10.1038/nrcardio.2015.191.
  18. Monomorphic ventricular tachycardia in patients with Brugada syndrome: A multicenter retrospective study.

    Rodríguez-Mañero, M, Sacher, F, de Asmundis, C, Maury, P, Lambiase, PD, Sarkozy, A et al..

    Heart Rhythm. 2016;13 (3):669-82.

    PubMed PMID:26538325.

    doi: 10.1016/j.hrthm.2015.10.038.
  19. Catheter ablation of atrial fibrillation in patients with diabetes mellitus: a systematic review and meta-analysis.

    Anselmino, M, Matta, M, D'ascenzo, F, Pappone, C, Santinelli, V, Bunch, TJ et al..

    Europace. 2015;17 (10):1518-25.

    PubMed PMID:26498716.

    doi: 10.1093/europace/euv214.
  20. Use of a contact force-sensing ablation catheter with advanced catheter location significantly reduces fluoroscopy time and radiation dose in catheter ablation of atrial fibrillation.

    Lee, G, Hunter, RJ, Lovell, MJ, Finlay, M, Ullah, W, Baker, V et al..

    Europace. 2016;18 (2):211-8.

    PubMed PMID:26318548.

    doi: 10.1093/europace/euv186.
  21. The Hot and the Cold: Radiofrequency Versus Cryoballoon Ablation for Atrial Fibrillation.

    Ang, R, Domenichini, G, Finlay, MC, Schilling, RJ, Hunter, RJ.

    Curr Cardiol Rep. 2015;17 (9):631.

    PubMed PMID:26266757.

    doi: 10.1007/s11886-015-0631-7.
  22. Impact of Catheter Contact Force on Human Left Atrial Electrogram Characteristics in Sinus Rhythm and Atrial Fibrillation.

    Ullah, W, Hunter, RJ, Baker, V, Ling, LH, Dhinoja, MB, Sporton, S et al..

    Circ Arrhythm Electrophysiol. 2015;8 (5):1030-9.

    PubMed PMID:26152560.

    doi: 10.1161/CIRCEP.114.002483.
  23. Evolution of Electrocardiographic and Structural Features Over 3 Decades in Arrhythmogenic Cardiomyopathy.

    Abrams, DJ, Kirkby, C, Page, SP, Earley, MJ, Nitiou, D, Kelsell, DP et al..

    Circulation. 2015;131 (25):2233-5.

    PubMed PMID:26099957.

    doi: 10.1161/CIRCULATIONAHA.115.014371.
  24. Pulmonary vein measurements on pre-procedural CT/MR imaging can predict difficult pulmonary vein isolation and phrenic nerve injury during cryoballoon ablation for paroxysmal atrial fibrillation.

    Ang, R, Hunter, RJ, Baker, V, Richmond, L, Dhinoja, M, Sporton, S et al..

    Int. J. Cardiol. 2015;195 :253-8.

    PubMed PMID:26048388.

    doi: 10.1016/j.ijcard.2015.05.089.
  25. T-wave oversensing in patients with Brugada syndrome: true bipolar versus integrated bipolar implantable cardioverter defibrillator leads: multicenter retrospective study.

    Rodríguez-Mañero, M, de Asmundis, C, Sacher, F, Arbelo, E, Probst, V, Castro-Hevia, J et al..

    Circ Arrhythm Electrophysiol. 2015;8 (4):792-8.

    PubMed PMID:26041387.

    doi: 10.1161/CIRCEP.115.002871.
  26. Ambulatory respiratory rate trends identify patients at higher risk of worsening heart failure in implantable cardioverter defibrillator and biventricular device recipients: a novel ambulatory parameter to optimize heart failure management.

    Goetze, S, Zhang, Y, An, Q, Averina, V, Lambiase, P, Schilling, R et al..

    J Interv Card Electrophysiol. 2015;43 (1):21-9.

    PubMed PMID:25863797. PubMed Central PMC4438200.

    doi: 10.1007/s10840-015-9983-6.
  27. Increased prothrombotic profile in the left atrial appendage of atrial fibrillation patients.

    Breitenstein, A, Glanzmann, M, Falk, V, Maisano, F, Stämpfli, SF, Holy, EW et al..

    Int. J. Cardiol. 2015;185 :250-5.

    PubMed PMID:25814212.

    doi: 10.1016/j.ijcard.2015.03.092.
  28. Response to letter regarding "Catheter ablation of atrial fibrillation in patients with left ventricular systolic dysfunction: a systematic review and meta-analysis".

    Anselmino, M, Matta, M, D'Ascenzo, F, Bunch, TJ, Schilling, RJ, Hunter, RJ et al..

    Circ Arrhythm Electrophysiol. 2015;8 (1):246.

    PubMed PMID:25691564.

    doi: 10.1161/CIRCEP.115.002697.
  29. A highly effective technique for transseptal endocardial left ventricular lead placement for delivery of cardiac resynchronization therapy.

    Domenichini, G, Diab, I, Campbell, NG, Dhinoja, M, Hunter, RJ, Sporton, S et al..

    Heart Rhythm. 2015;12 (5):943-9.

    PubMed PMID:25638701.

    doi: 10.1016/j.hrthm.2015.01.038.
  30. Relationship between contact force sensing technology and medium-term outcome of atrial fibrillation ablation: a multicenter study of 600 patients.

    Jarman, JW, Panikker, S, DAS, M, Wynn, GJ, Ullah, W, Kontogeorgis, A et al..

    J. Cardiovasc. Electrophysiol. 2015;26 (4):378-84.

    PubMed PMID:25546580.

    doi: 10.1111/jce.12606.
  31. RE-CIRCUIT study-randomized evaluation of Dabigatran etexilate compared to warfarin in pulmonary vein ablation: assessment of an uninterrupted periprocedural anticoagulation strategy.

    Calkins, H, Gerstenfeld, EP, Schilling, R, Verma, A, Willems, S, RE-CIRCUIT Study Steering Committee et al..

    Am. J. Cardiol. 2015;115 (1):154-5.

    PubMed PMID:25456859.

    doi: 10.1016/j.amjcard.2014.10.002.
  32. Defining disease phenotypes using national linked electronic health records: a case study of atrial fibrillation.

    Morley, KI, Wallace, J, Denaxas, SC, Hunter, RJ, Patel, RS, Perel, P et al..

    PLoS ONE. 2014;9 (11):e110900.

    PubMed PMID:25369203. PubMed Central PMC4219705.

    doi: 10.1371/journal.pone.0110900.
  33. Impact of steerable sheaths on contact forces and reconnection sites in ablation for persistent atrial fibrillation.

    Ullah, W, Hunter, RJ, McLean, A, Dhinoja, M, Earley, MJ, Sporton, S et al..

    J. Cardiovasc. Electrophysiol. 2015;26 (3):266-73.

    PubMed PMID:25346514.

    doi: 10.1111/jce.12573.
  34. Catheter ablation of atrial fibrillation in patients with left ventricular systolic dysfunction: a systematic review and meta-analysis.

    Anselmino, M, Matta, M, D'Ascenzo, F, Bunch, TJ, Schilling, RJ, Hunter, RJ et al..

    Circ Arrhythm Electrophysiol. 2014;7 (6):1011-8.

    PubMed PMID:25262686.

    doi: 10.1161/CIRCEP.114.001938.
  35. Comparison of robotic and manual persistent AF ablation using catheter contact force sensing: an international multicenter registry study.

    Ullah, W, Hunter, RJ, Haldar, S, McLean, A, Dhinoja, M, Sporton, S et al..

    Pacing Clin Electrophysiol. 2014;37 (11):1427-35.

    PubMed PMID:25220575.

    doi: 10.1111/pace.12501.
  36. Factors affecting catheter contact in the human left atrium and their impact on ablation efficacy.

    Ullah, W, Hunter, RJ, Baker, V, Dhinoja, MB, Sporton, S, Earley, MJ et al..

    J. Cardiovasc. Electrophysiol. 2015;26 (2):129-36.

    PubMed PMID:25213917.

    doi: 10.1111/jce.12542.
  37. Use of avatar virtual conferencing to co-ordinate cardiac multi-centre research.

    Haywood, GA, Davies, EJ, Boulos, MN, Rapanotti, L, Schilling, R, Todd, D et al..

    Int. J. Cardiol. 2014;176 (3):1086-8.

    PubMed PMID:25150495.

    doi: 10.1016/j.ijcard.2014.07.125.
  38. Does modification to the approach to contacting potential participants improve recruitment to clinical trials?.

    Sawhney, V, Graham, A, Campbell, N, Schilling, R.

    J Clin Med Res. 2014;6 (5):384-7.

    PubMed PMID:25110544. PubMed Central PMC4125335.

    doi: 10.14740/jocmr1879w.
  39. Frequent and possibly inappropriate use of combination therapy with an oral anticoagulant and antiplatelet agents in patients with atrial fibrillation in Europe.

    De Caterina, R, Ammentorp, B, Darius, H, Le Heuzey, JY, Renda, G, Schilling, RJ et al..

    Heart. 2014;100 (20):1625-35.

    PubMed PMID:25106421.

    doi: 10.1136/heartjnl-2014-305486.
  40. Predictors of new onset atrial fibrillation in patients with heart failure.

    Campbell, NG, Cantor, EJ, Sawhney, V, Duncan, ER, DeMartini, C, Baker, V et al..

    Int. J. Cardiol. 2014;175 (2):328-32.

    PubMed PMID:24985070.

    doi: 10.1016/j.ijcard.2014.05.023.
  41. Randomized trial comparing robotic to manual ablation for atrial fibrillation.

    Ullah, W, McLean, A, Hunter, RJ, Baker, V, Richmond, L, Cantor, EJ et al..

    Heart Rhythm. 2014;11 (11):1862-9.

    PubMed PMID:24960268.

    doi: 10.1016/j.hrthm.2014.06.026.
  42. The management of atrial fibrillation: summary of updated NICE guidance.

    Jones, C, Pollit, V, Fitzmaurice, D, Cowan, C, Guideline Development Group.

    BMJ. 2014;348 :g3655.

    PubMed PMID:24948694.

    .
  43. Robotics in invasive cardiac electrophysiology.

    Shurrab, M, Schilling, R, Gang, E, Khan, EM, Crystal, E.

    Expert Rev Med Devices. 2014;11 (4):375-81.

    PubMed PMID:24793740.

    doi: 10.1586/17434440.2014.916207.
  44. Practical ways to reduce radiation dose for patients and staff during device implantations and electrophysiological procedures.

    Heidbuchel, H, Wittkampf, FH, Vano, E, Ernst, S, Schilling, R, Picano, E et al..

    Europace. 2014;16 (7):946-64.

    PubMed PMID:24792380.

    doi: 10.1093/europace/eut409.
  45. Improving anticoagulation in atrial fibrillation: observational study in three primary care trusts.

    Robson, J, Dostal, I, Mathur, R, Sohanpal, R, Hull, S, Antoniou, S et al..

    Br J Gen Pract. 2014;64 (622):e275-81.

    PubMed PMID:24771841. PubMed Central PMC4001131.

    doi: 10.3399/bjgp14X679705.
  46. Differences among western European countries in anticoagulation management of atrial fibrillation. Data from the PREFER IN AF registry.

    Le Heuzey, JY, Ammentorp, B, Darius, H, De Caterina, R, Schilling, RJ, Schmitt, J et al..

    Thromb. Haemost. 2014;111 (5):833-41.

    PubMed PMID:24651882.

    doi: 10.1160/TH13-12-1007.
  47. Periprocedural stroke risk in patients undergoing catheter ablation for atrial fibrillation on uninterrupted warfarin.

    Page, SP, Herring, N, Hunter, RJ, Withycombe, E, Lovell, M, Wali, G et al..

    J. Cardiovasc. Electrophysiol. 2014;25 (6):585-90.

    PubMed PMID:24641450.

    doi: 10.1111/jce.12411.
  48. [Management of thromboembolic risk in patients with atrial fibrillation in Italy: baseline data from the PREFER in AF European Registry].

    De Caterina, R, Renda, G, Sangiuolo, R, Attena, E, Di Lecce, L, Romeo, F et al..

    G Ital Cardiol (Rome). 2014;15 (2):99-109.

    PubMed PMID:24625849.

    doi: 10.1714/1424.15779.
  49. Target indices for clinical ablation in atrial fibrillation: insights from contact force, electrogram, and biophysical parameter analysis.

    Ullah, W, Hunter, RJ, Baker, V, Dhinoja, MB, Sporton, S, Earley, MJ et al..

    Circ Arrhythm Electrophysiol. 2014;7 (1):63-8.

    PubMed PMID:24443504.

    doi: 10.1161/CIRCEP.113.001137.
  50. A randomized controlled trial of catheter ablation versus medical treatment of atrial fibrillation in heart failure (the CAMTAF trial).

    Hunter, RJ, Berriman, TJ, Diab, I, Kamdar, R, Richmond, L, Baker, V et al..

    Circ Arrhythm Electrophysiol. 2014;7 (1):31-8.

    PubMed PMID:24382410.

    doi: 10.1161/CIRCEP.113.000806.
  51. The C-CURE Randomized Clinical Trial (Cardiopoietic stem Cell therapy in heart failURE).

    Mielewczik, M, Cole, GD, Nowbar, AN, Schilling, R, Whinnett, ZI, Bordachar, P et al..

    J. Am. Coll. Cardiol. 2013;62 (25):2453.

    PubMed PMID:24355589.

    doi: 10.1016/j.jacc.2013.09.013.
  52. Management of atrial fibrillation in seven European countries after the publication of the 2010 ESC Guidelines on atrial fibrillation: primary results of the PREvention oF thromboemolic events--European Registry in Atrial Fibrillation (PREFER in AF).

    Kirchhof, P, Ammentorp, B, Darius, H, De Caterina, R, Le Heuzey, JY, Schilling, RJ et al..

    Europace. 2014;16 (1):6-14.

    PubMed PMID:24084680. PubMed Central PMC3864758.

    doi: 10.1093/europace/eut263.
  53. Effect of atrial fibrillation ablation on myocardial function: insights from cardiac magnetic resonance feature tracking analysis.

    Ceelen, F, Hunter, RJ, Boubertakh, R, Sommer, WH, Armbruster, M, Schilling, RJ et al..

    Int J Cardiovasc Imaging. 2013;29 (8):1807-17.

    PubMed PMID:24002783.

    doi: 10.1007/s10554-013-0287-6.
  54. Utility of mapping signals to improve precision of atrioventricular node ablation.

    Yeo, WT, Sporton, SC, Dhinoja, M, Schilling, RJ, Earley, MJ.

    Pacing Clin Electrophysiol. 2013;36 (11):1357-63.

    PubMed PMID:23763518.

    doi: 10.1111/pace.12199.
  55. Are patients admitted to emergency departments with regular supraventricular tachycardia (SVT) treated appropriately?.

    Sawhney, V, Corden, B, Abdul-Mukith, K, Harris, T, Schilling, RJ.

    Clin Med (Lond). 2013;13 (2):146-8.

    PubMed PMID:23681861.

    doi: 10.7861/clinmedicine.13-2-146.
  56. Three-dimensional localization versus fluoroscopically only guided ablations: a meta-analysis.

    Shurrab, M, Laish-Farkash, A, Lashevsky, I, Morriello, F, Singh, SM, Schilling, RJ et al..

    Scand. Cardiovasc. J. 2013;47 (4):200-9.

    PubMed PMID:23647246.

    doi: 10.3109/14017431.2013.797099.
  57. The Prevalence of Low Left Atrial Appendage Emptying Velocity and Thrombus in Patients Undergoing Catheter Ablation for Atrial Fibrillation on Uninterrupted Peri-procedural Warfarin Therapy.

    Herring, N, Page, SP, Ahmed, M, Burg, MR, Hunter, RJ, Earley, MJ et al..

    J Atr Fibrillation. ;5 (6):761.

    PubMed PMID:28496828. PubMed Central PMC5153174.

    doi: 10.4022/jafib.761.
  58. Current genomics in cardiovascular medicine.

    Sawhney, V, Brouilette, S, Abrams, D, Schilling, R, O'Brien, B.

    Curr. Genomics. 2012;13 (6):446-62.

    PubMed PMID:23450299. PubMed Central PMC3426779.

    doi: 10.2174/138920212802510484.
  59. Impact of controlling atrial fibrillation on outcomes relevant to the patient: focus on dronedarone.

    Chahal, CA, Ali, O, Hunter, RJ, Schilling, RJ.

    Patient Relat Outcome Meas. 2012;3 :95-103.

    PubMed PMID:23378791. PubMed Central PMC3557702.

    doi: 10.2147/PROM.S16678.
  60. Diagnostic accuracy of cardiac magnetic resonance imaging in the detection and characterization of left atrial catheter ablation lesions: a multicenter experience.

    Hunter, RJ, Jones, DA, Boubertakh, R, Malcolme-Lawes, LC, Kanagaratnam, P, Juli, CF et al..

    J. Cardiovasc. Electrophysiol. 2013;24 (4):396-403.

    PubMed PMID:23293924.

    doi: 10.1111/jce.12063.
  61. Epicardial catheter ablation for ventricular tachycardia in heparinized patients.

    Page, SP, Duncan, ER, Thomas, G, Ginks, MR, Earley, MJ, Sporton, SC et al..

    Europace. 2013;15 (2):284-9.

    PubMed PMID:23002196.

    doi: 10.1093/europace/eus258.
  62. Seek referral to a heart rhythm specialist for atrial fibrillation.

    Schilling, RJ, Camm, J, Lip, G, Grace, A, Fay, M, Fitzpatrick, A et al..

    BMJ. 2012;344 :e4318.

    PubMed PMID:22734100.

    .
  63. Improved electrogram attenuation during ablation of paroxysmal atrial fibrillation with the Hansen robotic system.

    Duncan, ER, Finlay, M, Page, SP, Hunter, R, Goromonzi, F, Richmond, L et al..

    Pacing Clin Electrophysiol. 2012;35 (6):730-8.

    PubMed PMID:22494451.

    doi: 10.1111/j.1540-8159.2012.03381.x.
  64. Left atrial wall stress distribution and its relationship to electrophysiologic remodeling in persistent atrial fibrillation.

    Hunter, RJ, Liu, Y, Lu, Y, Wang, W, Schilling, RJ.

    Circ Arrhythm Electrophysiol. 2012;5 (2):351-60.

    PubMed PMID:22294615.

    doi: 10.1161/CIRCEP.111.965541.
  65. A randomised comparison of Cartomerge vs. NavX fusion in the catheter ablation of atrial fibrillation: the CAVERN Trial.

    Finlay, MC, Hunter, RJ, Baker, V, Richmond, L, Goromonzi, F, Thomas, G et al..

    J Interv Card Electrophysiol. 2012;33 (2):161-9.

    PubMed PMID:22119854. PubMed Central PMC3305875.

    doi: 10.1007/s10840-011-9632-7.
  66. First prospective, multi-centre clinical experience with a novel left ventricular quadripolar lead.

    Sperzel, J, Dänschel, W, Gutleben, KJ, Kranig, W, Mortensen, P, Connelly, D et al..

    Europace. 2012;14 (3):365-72.

    PubMed PMID:21993431.

    doi: 10.1093/europace/eur322.
  67. Dual ventricular response: what is the mechanism?.

    Page, SP, Pfeffer, C, Schilling, RJ, Sporton, SC.

    J. Cardiovasc. Electrophysiol. 2012;23 (6):669-71.

    PubMed PMID:21954989.

    doi: 10.1111/j.1540-8167.2011.02174.x.
  68. Maintenance of sinus rhythm with an ablation strategy in patients with atrial fibrillation is associated with a lower risk of stroke and death.

    Hunter, RJ, McCready, J, Diab, I, Page, SP, Finlay, M, Richmond, L et al..

    Heart. 2012;98 (1):48-53.

    PubMed PMID:21930724.

    doi: 10.1136/heartjnl-2011-300720.
  69. Characterization of fractionated atrial electrograms critical for maintenance of atrial fibrillation: a randomized, controlled trial of ablation strategies (the CFAE AF trial).

    Hunter, RJ, Diab, I, Tayebjee, M, Richmond, L, Sporton, S, Earley, MJ et al..

    Circ Arrhythm Electrophysiol. 2011;4 (5):622-9.

    PubMed PMID:21844156.

    doi: 10.1161/CIRCEP.111.962928.
  70. Does ventricular dyssynchrony on echocardiography predict response to cardiac resynchronisation therapy? A randomised controlled study.

    Diab, IG, Hunter, RJ, Kamdar, R, Berriman, T, Duncan, E, Richmond, L et al..

    Heart. 2011;97 (17):1410-6.

    PubMed PMID:21700757.

    doi: 10.1136/hrt.2011.227686.
  71. Pulmonary vein isolation with radiofrequency ablation followed by cryotherapy: a novel strategy to improve clinical outcomes following catheter ablation of paroxysmal atrial fibrillation.

    Tayebjee, MH, Hunter, RJ, Baker, V, Creta, A, Duncan, E, Sporton, S et al..

    Europace. 2011;13 (9):1250-5.

    PubMed PMID:21572091.

    doi: 10.1093/europace/eur140.
  72. New European guidelines on atrial fibrillation.

    Hunter, RJ, Schilling, RJ.

    BMJ. 2011;342 :d897.

    PubMed PMID:21339282.

    .
  73. Routine transthoracic echocardiography to assess pericardial collections in patients after extensive left atrial catheter ablation: a prospective study.

    Kalla, M, Rajappan, K, Kalra, S, Thomas, G, Redpath, C, Earley, MJ et al..

    J. Cardiovasc. Electrophysiol. 2011;22 (7):756-60.

    PubMed PMID:21288280.

    doi: 10.1111/j.1540-8167.2010.02008.x.
  74. Isolated left atrial standstill identified during catheter ablation.

    Duncan, E, Schilling, RJ, Earley, M.

    Pacing Clin Electrophysiol. 2013;36 (4):e120-4.

    PubMed PMID:21070263.

    doi: 10.1111/j.1540-8159.2010.02957.x.
  75. Catheter ablation for atrial fibrillation on uninterrupted warfarin: can it be done without echo guidance?.

    Page, SP, Siddiqui, MS, Finlay, M, Hunter, RJ, Abrams, DJ, Dhinoja, M et al..

    J. Cardiovasc. Electrophysiol. 2011;22 (3):265-70.

    PubMed PMID:21040095.

    doi: 10.1111/j.1540-8167.2010.01910.x.
  76. Part 8: Advanced life support: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations.

    Morrison, LJ, Deakin, CD, Morley, PT, Callaway, CW, Kerber, RE, Kronick, SL et al..

    Circulation. 2010;122 (16 Suppl 2):S345-421.

    PubMed PMID:20956256.

    doi: 10.1161/CIRCULATIONAHA.110.971051.
  77. Impact of variant pulmonary vein anatomy and image integration on long-term outcome after catheter ablation for atrial fibrillation.

    Hunter, RJ, Ginks, M, Ang, R, Diab, I, Goromonzi, FC, Page, S et al..

    Europace. 2010;12 (12):1691-7.

    PubMed PMID:20823042.

    doi: 10.1093/europace/euq322.
  78. Do traditional VT zones improve outcome in primary prevention ICD patients?.

    Duncan, E, Thomas, G, Johns, N, Pfeffer, C, Appanna, G, Shah, N et al..

    Pacing Clin Electrophysiol. 2010;33 (11):1353-8.

    PubMed PMID:20727095.

    doi: 10.1111/j.1540-8159.2010.02859.x.
  79. Impact of angiotensin-converting enzyme-inhibitors and angiotensin receptor blockers on long-term outcome of catheter ablation for atrial fibrillation.

    Tayebjee, MH, Creta, A, Moder, S, Hunter, RJ, Earley, MJ, Dhinoja, MB et al..

    Europace. 2010;12 (11):1537-42.

    PubMed PMID:20682557.

    doi: 10.1093/europace/euq284.
  80. Robotic catheter navigation within the left ventricle.

    Duncan, E, Johns, N, Schilling, RJ, Sporton, S.

    Pacing Clin Electrophysiol. 2011;34 (11):102-4.

    PubMed PMID:20663076.

    doi: 10.1111/j.1540-8159.2010.02824.x.
  81. Long-term outcome after catheter ablation for atrial fibrillation: safety, efficacy and impact on prognosis.

    Hunter, RJ, Schilling, RJ.

    Heart. 2010;96 (16):1259-63.

    PubMed PMID:20659943.

    doi: 10.1136/hrt.2010.194613.
  82. Iatrogenic asystole on the ITU.

    Sawhney, V, Ezzat, VA, Sharp, AS, Schilling, RJ.

    Lancet. 2010;376 (9736):204.

    PubMed PMID:20638566.

    doi: 10.1016/S0140-6736(10)60702-7.
  83. Intracoronary ethanol ablation: a novel technique for ablation of ventricular fibrillation.

    Duncan, E, Schilling, RJ.

    Heart Rhythm. 2010;7 (8):1131-4.

    PubMed PMID:20394841.

    doi: 10.1016/j.hrthm.2010.04.012.
  84. Cryoablation versus radiofrequency ablation for treatment of atrioventricular nodal reentrant tachycardia: cryoablation with 6-mm-tip catheters is still less effective than radiofrequency ablation.

    Opel, A, Murray, S, Kamath, N, Dhinoja, M, Abrams, D, Sporton, S et al..

    Heart Rhythm. 2010;7 (3):340-3.

    PubMed PMID:20185106.

    doi: 10.1016/j.hrthm.2009.11.029.
  85. Termination of atrial fibrillation by flecainide: mechanistic insights from spectral analysis.

    Hunter, RJ, Schilling, RJ.

    Europace. 2010;12 (4):453-4.

    PubMed PMID:20167613.

    doi: 10.1093/europace/euq011.
  86. Venice Chart International Consensus document on ventricular tachycardia/ventricular fibrillation ablation.

    Natale, A, Raviele, A, Al-Ahmad, A, Alfieri, O, Aliot, E, Almendral, J et al..

    J. Cardiovasc. Electrophysiol. 2010;21 (3):339-79.

    PubMed PMID:20082650.

    doi: 10.1111/j.1540-8167.2009.01686.x.
  87. Distinguishing far-field appendage from local pulmonary vein signal in the left upper pulmonary vein during atrial tachycardia.

    Duncan, E, Tayebjee, M, Schilling, RJ.

    J. Cardiovasc. Electrophysiol. 2010;21 (4):469-72.

    PubMed PMID:20021513.

    doi: 10.1111/j.1540-8167.2009.01669.x.
  88. The NICE guidelines for percutaneous epicardial catheter ablation of ventricular tachycardia: symptomatic of a guideline-obsessed health service?.

    Schilling, RJ, Sporton, SC, Earley, MS, National Institute for Clinical Excellence (NICE).

    Heart. 2010;96 (3):229-30.

    PubMed PMID:19910290.

    doi: 10.1136/hrt.2009.182915.
  89. Cardioversion of atrial fibrillation: the use of antiarrhythmic drugs.

    Schilling, RJ.

    Heart. 2010;96 (5):333-8.

    PubMed PMID:19910286.

    doi: 10.1136/hrt.2008.155812.
  90. Validation of a classification system to grade fractionation in atrial fibrillation and correlation with automated detection systems.

    Hunter, RJ, Diab, I, Thomas, G, Duncan, E, Abrams, D, Dhinoja, M et al..

    Europace. 2009;11 (12):1587-96.

    PubMed PMID:19897499.

    doi: 10.1093/europace/eup351.
  91. A prospective comparison of echocardiography and device algorithms for atrioventricular and interventricular interval optimization in cardiac resynchronization therapy.

    Kamdar, R, Frain, E, Warburton, F, Richmond, L, Mullan, V, Berriman, T et al..

    Europace. 2010;12 (1):84-91.

    PubMed PMID:19892713.

    doi: 10.1093/europace/eup337.
  92. Uninterrupted warfarin for periprocedural anticoagulation in catheter ablation of typical atrial flutter: a safe and cost-effective strategy.

    Finlay, M, Sawhney, V, Schilling, R, Thomas, G, Duncan, E, Hunter, R et al..

    J. Cardiovasc. Electrophysiol. 2010;21 (2):150-4.

    PubMed PMID:19793142.

    doi: 10.1111/j.1540-8167.2009.01603.x.
  93. A broad complex tachycardia with conflicting information from pacing manoeuvres.

    Hunter, RJ, Finlay, M, Schilling, RJ, Sporton, S.

    Europace. 2009;11 (10):1392-5.

    PubMed PMID:19592410.

    doi: 10.1093/europace/eup190.
  94. EHRA/HRS Expert Consensus on Catheter Ablation of Ventricular Arrhythmias: developed in a partnership with the European Heart Rhythm Association (EHRA), a Registered Branch of the European Society of Cardiology (ESC), and the Heart Rhythm Society (HRS); in collaboration with the American College of Cardiology (ACC) and the American Heart Association (AHA).

    Aliot, EM, Stevenson, WG, Almendral-Garrote, JM, Bogun, F, Calkins, CH, Delacretaz, E et al..

    Heart Rhythm. 2009;6 (6):886-933.

    PubMed PMID:19467519.

    doi: 10.1016/j.hrthm.2009.04.030.
  95. EHRA/HRS Expert Consensus on Catheter Ablation of Ventricular Arrhythmias: developed in a partnership with the European Heart Rhythm Association (EHRA), a Registered Branch of the European Society of Cardiology (ESC), and the Heart Rhythm Society (HRS); in collaboration with the American College of Cardiology (ACC) and the American Heart Association (AHA).

    Aliot, EM, Stevenson, WG, Almendral-Garrote, JM, Bogun, F, Calkins, CH, Delacretaz, E et al..

    Europace. 2009;11 (6):771-817.

    PubMed PMID:19443434.

    doi: 10.1093/europace/eup098.
  96. A randomized-controlled trial comparing conventional with minimal catheter approaches for the mapping and ablation of regular supraventricular tachycardias.

    Liew, R, Baker, V, Richmond, L, Rajappan, K, Gupta, D, Finlay, M et al..

    Europace. 2009;11 (8):1057-64.

    PubMed PMID:19411675.

    doi: 10.1093/europace/eup108.
  97. A randomized trial to compare atrial fibrillation ablation using a steerable vs. a non-steerable sheath.

    Rajappan, K, Baker, V, Richmond, L, Kistler, PM, Thomas, G, Redpath, C et al..

    Europace. 2009;11 (5):571-5.

    PubMed PMID:19351628.

    doi: 10.1093/europace/eup069.
  98. Acute and chronic pulmonary vein reconnection after atrial fibrillation ablation: a prospective characterization of anatomical sites.

    Rajappan, K, Kistler, PM, Earley, MJ, Thomas, G, Izquierdo, M, Sporton, SC et al..

    Pacing Clin Electrophysiol. 2008;31 (12):1598-605.

    PubMed PMID:19067813.

    doi: 10.1111/j.1540-8159.2008.01232.x.
  99. The impact of image integration on catheter ablation of atrial fibrillation using electroanatomic mapping: a prospective randomized study.

    Kistler, PM, Rajappan, K, Harris, S, Earley, MJ, Richmond, L, Sporton, SC et al..

    Eur. Heart J. 2008;29 (24):3029-36.

    PubMed PMID:18931059.

    doi: 10.1093/eurheartj/ehn453.
  100. Validation of computed tomography image integration into the EnSite NavX mapping system to perform catheter ablation of atrial fibrillation.

    Richmond, L, Rajappan, K, Voth, E, Rangavajhala, V, Earley, MJ, Thomas, G et al..

    J. Cardiovasc. Electrophysiol. 2008;19 (8):821-7.

    PubMed PMID:18373607.

    doi: 10.1111/j.1540-8167.2008.01127.x.
Search PubMed